DUSP22 | Dual specificity phosphatase 22 | Enzymes
| | | | | Expressed in all |
IRF4 | Interferon regulatory factor 4 | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
FOXQ1 | Forkhead box Q1 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
WRNIP1 | Werner helicase interacting protein 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
SERPINB9 | Serpin peptidase inhibitor, clade B (ovalbumin), member 9 | | | | | | Mixed |
SERPINB6 | Serpin peptidase inhibitor, clade B (ovalbumin), member 6 | Disease related genes Plasma proteins
| | | | | Expressed in all |
NQO2 | NAD(P)H dehydrogenase, quinone 2 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
RIPK1 | Receptor (TNFRSF)-interacting serine-threonine kinase 1 | Enzymes
| | | | | Expressed in all |
BPHL | Biphenyl hydrolase-like (serine hydrolase) | | | | | | Expressed in all |
ECI2 | Enoyl-CoA delta isomerase 2 | Enzymes
| | | | | Expressed in all |
CDYL | Chromodomain protein, Y-like | Enzymes
| | | | | Expressed in all |
LYRM4 | LYR motif containing 4 | Disease related genes
| | | | | Expressed in all |
F13A1 | Coagulation factor XIII, A1 polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
LY86 | Lymphocyte antigen 86 | Predicted secreted proteins
| | | | | Tissue enhanced |
SSR1 | Signal sequence receptor, alpha | Predicted membrane proteins
| | | | | Expressed in all |
RIOK1 | RIO kinase 1 | Enzymes
| | | | | Expressed in all |
DSP | Desmoplakin | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Group enriched |
TXNDC5 | Thioredoxin domain containing 5 (endoplasmic reticulum) | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
C6orf52 | Chromosome 6 open reading frame 52 | | | | | | Tissue enhanced |
PAK1IP1 | PAK1 interacting protein 1 | | | | | | Expressed in all |
EDN1 | Endothelin 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
PHACTR1 | Phosphatase and actin regulator 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
SIRT5 | Sirtuin 5 | FDA approved drug targets
| | | | | Expressed in all |
NOL7 | Nucleolar protein 7, 27kDa | | | | | | Expressed in all |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
JARID2 | Jumonji, AT rich interactive domain 2 | Plasma proteins Transcription factors
| | | | | Expressed in all |
DTNBP1 | Dystrobrevin binding protein 1 | Disease related genes
| | | | | Expressed in all |
CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | Cancer-related genes
| | | | | Tissue enhanced |
NUP153 | Nucleoporin 153kDa | | | | | | Expressed in all |
TPMT | Thiopurine S-methyltransferase | Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
DEK | DEK oncogene | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
HDGFL1 | Hepatoma derived growth factor-like 1 | | | | | | Tissue enriched |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
C6orf62 | Chromosome 6 open reading frame 62 | | | | | | Expressed in all |
GMNN | Geminin, DNA replication inhibitor | Cancer-related genes
| | | | | Expressed in all |
LRRC16A | Leucine rich repeat containing 16A | | | | | | Mixed |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins
| | | | | Tissue enhanced |
HIST1H2BA | Histone cluster 1, H2ba | | | | | | Tissue enriched |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
HIST1H3A | Histone cluster 1, H3a | | | | | | Tissue enhanced |
HIST1H4B | Histone cluster 1, H4b | Cancer-related genes Disease related genes
| | | | | Not detected |
HIST1H3B | Histone cluster 1, H3b | Cancer-related genes
| | | | | Tissue enriched |
HIST1H2AB | Histone cluster 1, H2ab | | | | | | Tissue enhanced |
HIST1H2BB | Histone cluster 1, H2bb | | | | | | Not detected |
HIST1H1C | Histone cluster 1, H1c | Plasma proteins
| | | | | Expressed in all |
HFE | Hemochromatosis | Disease related genes Predicted membrane proteins
| | | | | Mixed |
HIST1H2BC | Histone cluster 1, H2bc | Plasma proteins
| | | | | Mixed |
HIST1H2BD | Histone cluster 1, H2bd | | | | | | Expressed in all |